Skip to main content

Table 1 Patient demographic and clinical characteristics of each analytic sample

From: Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study

Characteristic

Direct costs Sample

n = 794

Societal costs

Sample

n = 220

HRQoL (EQ-5D-Y) Sample

n = 185

Age, mean (SD)

10.5 (4.74)

10.2 (4.58)

11.2 (3.79)

BMI z-score, mean (SD)

0.6 (1.59)

0.4 (1.46)

0.4 (1.39)

BMI, n (%)

 Underweight

24 (3)

12 (5)

8 (4)

 Normal weight

474 (60)

132 (60)

113 (61)

 Overweight

167 (21)

41 (19)

34 (18)

 Obese

129 (16)

35 (16)

30 (16)

Country, n (%)

 Germany

131 (16)

55 (25)

49 (26)

 Spain

182 (23)

40 (18)

27 (15)

 France

171 (22)

40 (18)

30 (16)

 Italy

197 (25)

38 (17)

35 (19)

 United Kingdom

113 (14)

47 (21)

44 (24)

Haemophilia type, n (%)

 A

627 (79)

168 (76)

143 (75)

 B

167 (21)

52 (24)

47 (25)

Severity, n (%)

 Moderate

331 (42)

58 (26)

43 (23)

 Severe

463 (58)

162 (74)

142 (77)

Comorbidities, n (%)

 0

648 (82)

178 (81)

151 (82)

 1

103 (13)

25 (11)

21 (11)

 ≥ 2

43 (5)

17 (8)

13 (7)

Treatment by severity*, n (%)

 Overall

n = 794

n = 220

n = 185

  No treatment

92 (12)

12 (5)

8 (4)

  On-demand

95 (12)

18 (8)

17 (9)

  Prophylaxis

607 (76)

190 (86)

160 (86)

 Moderate haemophilia

n = 332

n = 58

n = 43

  No treatment

91 (27)

12 (21)

8 (19)

  On-demand

48 (15)

1 (2)

3 (7)

  Prophylaxis

192 (58)

45 (78)

32 (74)

 Severe haemophilia

n = 462

n = 162

n = 142

  No treatment

1 (0.2)

0

0

  On-demand

47 (10)

17 (10)

14 (10)

  Prophylaxis

415 (90)

145 (90)

128 (90)

Annual bleeding rate, n (%)

 Overall

n = 794

n = 220

n = 185

  0

119 (15)

14 (6)

12 (6)

  1–5

609 (77)

182 (83)

152 (82)

  > 5

66 (8)

24 (11)

21 (11)

 Moderate

n = 331

n = 58

n = 43

  0

59 (18)

3 (5)

3 (7)

  1–5

255 (77)

50 (86)

35 (81)

  > 5

17 (5)

5 (9)

5 (12)

 Severe

n = 463

n = 162

n = 142

  0

60 (13)

11 (7)

9 (6)

  1–5

354 (76)

132 (81)

117 (82)

  > 5

49 (11)

19 (12)

16 (11)

Number of problem joints, n (%)

 Overall

n = 794

n = 220

n = 185

  0

694 (87)

177 (80)

151 (82)

  ≥ 1

100 (13)

43 (20)

34 (18)

 Moderate

n = 331

n = 58

n = 43

  0

299 (90)

48 (83)

37 (86)

  ≥ 1

32 (10)

10 (17)

6 (14)

 Severe

n = 463

n = 162

n = 142

  0

395 (85)

129 (80)

114 (80)

  ≥ 1

68 (15)

33 (20)

30 (20)

  1. Totals may not sum to 100% due to rounding
  2. BMI body mass index, SD standard deviation
  3. *“No treatment” category could include patients treated with alternative therapies such us desmopressin or antifibrinolytics